Revive Therapeutics Ltd. (OTCMKTS:RVVTF) stock is seeing a range bound trading in the opening session on Thursday.
As of 9:45, RVVTF stock jumped0.20% to $0.3770 with more than 25K shares, compared to its average volume of 1.04 million shares. The stock has moved within a range of $0.3660 – 0.3800 after opening the trade at $0.3660.
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics
- RVVTF announced it has entered into an agreement with the University of Health Sciences Antigua (“UHSA”) to collaborate on utilizing Revive’s novel psychedelic-assisted therapies and pioneering the clinical research and development of psychedelics in Antigua and Barbuda.
- Development of a Psychedelic treatment center in Antigua and Barbuda using Revive’s novel formulations and delivery forms of psychedelics, including its proprietary psilocybin oral-thin film product to treat mental health and substance abuse disorders;
- Research on UHSA’s campus will exclusively use Revive’s intellectual property, developed at the University of Wisconsin-Madison, with the aim to be the foundation for novel psychedelic therapies for research and commercial use in Antigua and Barbuda;
“We are excited to partner with UHSA as the relationship complements and accelerates our research and commercial goals with psychedelics and advances our patented drug delivery technology to deliver psychedelics in an oral thin film patch and topical forms in human clinical studies to support regulatory approvals globally,” said Derrick Welsh, COO of Psilocin Pharma, a division of the Company.